Addressing high drug costs, improving public health and ensuring patients are protected from surprise bills are important goals and FAH will continue to work with Congress towards long-term, material solutions. We appreciate Chairman Alexander and […]
Read More… from FAH Reacts to Draft Legislation Released by HELP Committee
FAH sent a letter to the House Ways and Means Committee Chairman Richard Neal (D-MA) and Ranking Member Kevin Brady (R-TX) in support of the Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act. In […]
This morning the leaders of seven major pharmaceutical companies are going to testify before the Senate Finance Committee. It is widely expected that they will downplay their role in the out-of-control price increases for lifesaving […]
Read More… from Before the Finger Pointing Begins – Here are the Facts about Drug Costs
